News | News By Subject | News by Disease News By Date | Search News

Depression News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
SAGE Therapeutics (SAGE) Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity     2/17/2017
Why Alkermes (ALKS)’ Depression Drug Candidate Has a Real Shot at Approval Despite Two Poor Trials     11/3/2016
Alkermes (ALKS) Rockets as Depression Drug Aces Key Late-Stage Trial     10/24/2016
SAGE Therapeutics (SAGE) Receives FDA Breakthrough Therapy Designation For SAGE-547 For The Treatment Of Postpartum Depression     9/6/2016
Janssen R&D Release: Esketamine Receives Breakthrough Therapy Designation from FDA for Major Depressive Disorder with Imminent Risk for Suicide     8/16/2016
Allergan (AGN), Gedeon Richter (RIG2.F) Face Setback in Cariprazine Antidepressant Trial     8/5/2016
SAGE Therapeutics (SAGE)' Stock Explodes as Drug Eliminates Postpartum Depression in Mid-Stage Study     7/14/2016
e-Therapeutics Sees Mixed Data in Major Depression Drug Trial     2/15/2016
Allergan (AGN)'s Rapastinel Snags Breakthrough Tag from the FDA for Depression     1/29/2016
Stock Craters as Alkermes (ALKS)' Depression Drug Fails in Two Late-Stage Trials     1/22/2016
Pfizer (PFE)'s Pristiq Fails to Beat Placebo in Phase III MDD Study     12/23/2015
Pfizer (PFE) Zoloft Co-Inventor Ken Koe Dies at 90 Years of Age     10/14/2015
Neurocrine Biosciences (NBIX)'s NBI-98854 Hits Primary Enpoint in Phase III Study     10/9/2015
Re-Analysis of GlaxoSmithKline (GSK)’s Seroxat/Paxil Antidepressant Data Shows Lack of Transparency     9/17/2015
Allergan (AGN) Coughs Up $560 Million Cash for Naurex     7/27/2015

News from Around the Web
First Blood Test To Accurately Diagnose Depression And Schizophrenia Developed, Yale Study Reveals     3/21/2017
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
Startup NeuroQore Uses Magnetic Pulses To Treat Depression. Does This Mean No More Drugs?     2/13/2017
Why Struggling Alkermes (ALKS) Could Make a Comeback in 2017     2/7/2017
This App Uses A Game To Fight Depression, University of Washington Study     1/11/2017
Zapping The Brain Really Does Seem To Improve Depression, Rio Grande Neurosciences Study     1/11/2017
Early-Life Language Stimulation, Skills May Prevent Childhood Depression, University of Missouri Study Reveals     9/8/2016
You Can Tell If You’re Depressed By Checking Instagram... Yes, Seriously, Harvard Study     8/22/2016
Prenatal BPA Exposure Linked To Anxiety And Depression In Boys, Columbia University Study     8/17/2016
Correcting Metabolic Deficiencies May Improve Depression Symptoms, University of Pittsburgh Study     8/15/2016
Music Electroacupuncture Outperforms Antidepressant Drug For Depression, Healthcare Medicine Institute Study     8/15/2016
Can This Ring Diagnose Your Depression? Helsinki Reveals     8/8/2016
This App Is Conquering Insomnia And Depression At The Same Time, Big Health Reveals     7/28/2016
The DNA That Makes You Happy Can Also Make You Sad, University of Oxford Study     7/19/2016
Brain Inflammation Linked To Depression In MS Patients, King's College London Study     7/8/2016

Press Releases
First Blood Test To Accurately Diagnose Depression And Schizophrenia Developed, Yale Study Reveals     3/21/2017
Neurocore Release: Just Published Scientific Paper Shows Positive Results Of Neurofeedback To Reduce Symptoms Of Anxiety And Depression     3/16/2017
Depression Study By Children's Hospital Los Angeles Investigators Is First To Determine In Vivo Evidence For Compensatory Neuroplasticity In Humans     3/10/2017
Mylan (MYL) Launches Generic Pristiq Tablets     3/10/2017
Breckenridge Pharmaceutical, Inc. Announces Launch Of Desvenlafaxine XR Tablets (Generic For Pristiq)     3/1/2017
Sunovion Announces Positive Topline Results From Study Evaluating Latuda (Lurasidone HCL) In Children And Adolescents With Bipolar Depression     2/27/2017
Takeda (TKPYY) And Cognition Kit Partner In Study To Pilot Wearable Software In Patients With Major Depressive Disorder (MDD)     2/23/2017
SAGE Therapeutics (SAGE) Advances SAGE-217 Into Placebo-Controlled Phase 2 Clinical Trial In Major Depressive Disorder     2/13/2017
Startup NeuroQore Uses Magnetic Pulses To Treat Depression. Does This Mean No More Drugs?     2/13/2017
Feinstein Institute Study Finds Medication Commonly Used During Labor Associated With Postpartum Depression     1/30/2017
Relmada Therapeutics Release: Announces FDA Acceptance Of IND And Authorization To Commence Phase 2a Clinical Trial For D-Methadone     1/26/2017
Adapt Pharma Release: NARCAN (Naloxone Hcl) Nasal Spray 2mg Approved By FDA     1/25/2017
University Of Eastern Finland Release: Antidepressant Use Increases Hip Fracture Risk Among Elderly     1/11/2017
Amorsa Therapeutics Announces Strategic Collaboration Facilitated By Johnson & Johnson Innovation (JNJ) To Develop New Therapy For Treatment-Resistant Depression     1/5/2017
SAGE Therapeutics (SAGE) Soars on Expedited Development of SAGE-547 Following Meeting With the FDA     12/6/2016

//-->